EMIR: an overview of the new framework

Tim Aron (Partner at Katten Muchin Rosenman UK LLP, London, UK)
Nathaniel Lalone (Associate at Katten Muchin Rosenman UK LLP, London, UK)
Carolyn Jackson (Partner, all at Katten Muchin Rosenman UK LLP, London, UK)

Journal of Investment Compliance

ISSN: 1528-5812

Publication date: 28 June 2013

Abstract

Purpose

The purpose of this paper is to explain the European Market Infrastructure Regulation, known as EMIR, adopted on July 4, 2012 as the Regulation on OTC Derivatives, Central Counterparties and Trade Repositories.

Design/methodology/approach

The paper explains EMIR's clearing and reporting requirements, who is within the scope of those requirements, who is a financial and non‐financial counterparty, the clearing thresholds, the clearing and reporting obligations, when those obligations will begin, the risk mitigation obligations, and a range of potential questions anyone trading in OTC derivatives should consider.

Findings

EMIR requires that all standardized OTC derivatives contracts be cleared through a central counterparty and reported to a trade repository.

Originality/value

The paper provides practical guidance by experienced financial services lawyers.

Keywords

Citation

Aron, T., Lalone, N. and Jackson, C. (2013), "EMIR: an overview of the new framework", Journal of Investment Compliance, Vol. 14 No. 2, pp. 57-60. https://doi.org/10.1108/JOIC-05-2013-0016

Download as .RIS

Publisher

:

Emerald Group Publishing Limited

Copyright © 2013, Authors

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.
To rent this content from Deepdyve, please click the button.